PMID: 11619511Oct 20, 2001Paper

Activism, drug regulation, and the politics of therapeutic evaluation in the AIDS era: a case study of ddC and the 'surrogate markers' debate

Social Studies of Science
S Epstein

Abstract

This paper presents an extended case study to demonstrate that the interpretation of clinical trials of antiviral AIDS drugs is significantly shaped by a widely dispersed allocation of scientific credibility. Specifically, the participation of AIDS activists in claims-making about AIDS trials and AIDS drugs complicates the politics of therapeutic evaluation, even as it challenges the monopolization of credibility by credentialed researchers. The paper tracks the social construction of belief about the efficacy of the combination therapy of AZT and ddC, between 1990 and 1995 in the United States. By intervening simultaneously in interpretative debates about the results of the clinical trials of this therapy and in methodological debates about how efficacy might best be measured in such trials, activists have helped to shape what is believed to be known about these drugs.

Citations

Apr 6, 2006·Critical Reviews in Biotechnology·Ajay SinghOwen Ward
Dec 15, 2015·Journal of the Air & Waste Management Association·Selnur Uçaroğlu, Ufuk Alkan
May 15, 2013·Waste Management·Akansha BhatiaAbsar Ahmed Kazmi
Apr 2, 2013·Journal of Environmental Management·Panagiota AvramidouDimitrios Komilis
Jan 15, 2013·Journal of Environmental Management·Bijaya K AdhikariMylène Daumoin
Oct 27, 2011·Water Research·Alexandros I StefanakisVassilios A Tsihrintzis
Mar 23, 2011·Waste Management·Ales HancPavel Svehla
May 14, 2011·Journal of Environmental Management·Dimitrios KomilisEvangelos Voudrias
Jul 21, 2010·Waste Management·Karolina Marešová, Mária Kollárová
Nov 21, 2009·Social Science & Medicine·Jenny Advocat, Jo Lindsay
Sep 29, 2009·Waste Management·Mohammad Ashik Iqbal KhanYoshitaka Ono
Jul 7, 2009·Journal of Hazardous Materials·Abdelbasset LakhdarChedly Abdelly
Apr 29, 2009·Waste Management·Ardavan MohajerMarco Carone
May 12, 2009·Bioresource Technology·Mark Farrell, Davey L Jones
Apr 22, 2009·Waste Management·M Himanen, K Hänninen
Apr 7, 2009·Waste Management·Valtcho D ZheljazkovPatrick D Gerard
Mar 6, 2009·Bioresource Technology·Francesco MontemurroGiambattista Debiase
Jan 2, 2009·Waste Management·Dimitrios P Komilis, Ioannis S Tziouvaras
Dec 2, 2008·Bioresource Technology·Hui Yu, Guo H Huang
Aug 20, 2008·Bioresource Technology·Shouhai YuJerry J Leonard
Feb 12, 2008·Waste Management·R CanetM A R Albiach
Feb 6, 2008·Bioresource Technology·N Gamze Turan
Dec 29, 2007·Waste Management·Ku-Yong KimHang-Sik Shin
Nov 13, 2007·Bioresource Technology·Shouhai YuJerry J Leonard
Nov 6, 2007·Waste Management·Danielle N AslamJean S VanderGheynst
Jul 4, 2007·Bioresource Technology·Li-An LuJih-Gaw Lin
Jun 1, 2007·Ecotoxicology and Environmental Safety·P BhattacharyyaM A Powell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.